Quality of life and control of allergic rhinitis in patients from regions beyond western Europe and the United States

Clinical and Experimental Allergy

Volumn 42, Issue 12, 2012, Pages 1684-1696

  Maspero, J ^a   Lee, B W ^b   Katelaris, C H ^c   Potter, P C ^d   Cingi, C ^e   Lopatin, A ^f   Saffer, M ^g   Nadeau, G ^h   Walters, R D ^h  

^a CABA   (Argentina)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^f PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^g Ambulatório de Otorrino Complexo Hospitalar Santa Casa de Porto Alegre   (Brazil)

^h GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Allergic rhinitis; Allergic rhinoconjunctivitis; Control; Diverse regions; Health related quality of life

Indexed keywords

ALLERGIC RHINITIS; ALLERGIC RHINOCONJUNCTIVITIS; DAILY LIFE ACTIVITY; EUROPE; HUMAN; MENTAL HEALTH; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RHINOCONJUNCTIVITIS; SLEEP; SOCIAL INTERACTION; UNITED STATES;

ARGENTINA; AUSTRALIA; BRAZIL; CONJUNCTIVITIS, ALLERGIC; HUMANS; QUALITY OF LIFE; RHINITIS, ALLERGIC, PERENNIAL; RUSSIA; SINGAPORE; SOUTH AFRICA; TURKEY;

EID: 84870161422     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2012.04025.x     Document Type: Review

References (80)

1. 2LEN and AllerGen). Allergy 2008; 63(Suppl 86):8-160.
2. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 2004; 24:758-64.
3. Bachert C, van Cauwenberge P, Olbrecht J, van Schoor J. Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy 2006; 61:693-8.
4. Nathan RA, Meltzer EO, Derebery J et al. The prevalence of nasal symptoms attributed to allergies in the United States: findings from the burden of rhinitis in an America survey. Allergy Asthma Proc 2008; 29:600-8.
5. Katelaris CH, Lee BW, Potter PC et al. Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America. Clin Exp Allergy 2012; 42:186-207.
6. Allergic Rhinitis and its Impact on Asthma (ARIA). http://www.whiar.org/Documents&Resources.php (accessed on 24th May 2011)
7. Bousquet J, Bodez T, Gehano P et al. Implementation of guidelines for allergic rhinitis in specialist practices. A randomized pragmatic controlled trial. Int Arch Allergy Immunol 2009; 150:75-82.
8. Bousquet J, Lund VJ, van Cauwenberge P et al. Implementation of guidelines for seasonal allergic rhinitis: a randomised controlled trial. Allergy 2003; 58:733-41.
9. Demoly P, Allaert F-A, Lecasble M, Klossek J-M, PRAGMA. ERAP, a pharmacoepidemiologic survey on perennial allergic rhinitis in every day medical practice in France. Presse Med 2003; 32:1066-72.
10. Demoly P, Allaert F-A, Lecasble M, PRAGMA. ERASM, a pharmacoepidemiologic survey on management of intermittent allergic rhinitis in every day general medical practice in France. Allergy 2002; 57:546-54.
11. Global Initiative for Asthma(GINA). GINA Report 2010 - Global Strategy for Asthma Management and Prevention. http://www.ginasthma.com/Guidelineitem (accessed on 24th May 2011).
12. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2010. http://www.goldcopd.org (accessed on 24th May 2011).
13. Meltzer EO, Nathan R, Derebery J et al. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey. Allergy Asthma Proc 2009; 30:244-54.
14. Meltzer EO, Blaiss MS, Derebery MJ et al. Burden of allergic rhinitis: results from the Pediatric Allergies in America survey. J Allergy Clin Immunol 2009; 124(3 Suppl):S43-70.
15. Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy 2007; 62(Suppl 85):17-25.
16. Blaiss MS. Pediatric allergic rhinitis: physical and mental complications. Allergy Asthma Proc 2007; 29:1-6.
17. van Wijk RG. Rhinits control: the next step. Clin Exp Allergy 2011; 41:773-4.
18. Baiardini I, Bousquet PJ, Brzoza Z et al. Global Allergy and Asthma European Network. Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. Allergy 2010; 65:290-5.
19. Braido F, Bousquet PJ, Brzoza Z et al. Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paper. Allergy 2010; 65:959-68.
20. Patrick DL, Burke LB, Powers JH et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health 2007; 10(Suppl 2):S125-37.
21. EMEA(CHMP). Reflection paper on the regulatory guidance for the use of health related quality of life (HRQL) measures in the evaluation of medicinal products. http://www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003637.pdf (accessed on 24th January 2012)
22. Chen H, Katz PP, Eisner MD, Yelin EH, Blanc PD. Health-related quality of life in adult rhinitis: the role of perceived control of disease. J Allergy Clin Immunol 2004; 114:845-50.
23. Sharp TJ, Seeto C. The psychosocial impact of self-reported morning allergy symptoms: findings from an Australian internet-based survey. J Allergy (Cairo) 2010; 2010:710926.
24. Rimmer J, Downie S, Bartlett DJ, Gralton J, Salome C. Sleep disturbance in persistent allergic rhinitis measured using actigraphy. Ann Allergy Asthma Immunol 2009; 103:190-4.
25. O'Connor J, Seeto C, Saini B et al. Healthcare professional versus patient goal setting in intermittent allergic rhinitis. Patient Educ Couns 2008; 70:111-7.
26. Downie SR, Andersson M, Rimmer J et al. Symptoms of persistent allergic rhinitis during a full calendar year in house dust mite sensitive subjects. Allergy 2004; 59:406-14.
27. Xue CC, Thien FC, Zhang JJ, Yang W, Da Costa C, Li CG. Effect of adding a Chinese herbal preparation to acupuncture for seasonal allergic rhinitis: randomised double-blind controlled trial. Hong Kong Med J 2003; 9:427-34.
28. Xue CC, Thien FC, Zhang JJ, Da Costa C, Li CG. Treatment for seasonal allergic rhinitis by Chinese herbal medicine: a randomized placebo controlled trial. Altern Ther Health Med 2003; 9:80-7.
29. Katelaris CH, Carrozzi FM, Burke TV, Byth K. A springtime olympics demands special consideration for allergic athletes. J Allergy Clin Immunol 2000; 106:260-6.
30. Katelaris CH, Carrozzi FM, Burke TV, Byth K. Effects of intranasal budesonide on symptoms, quality of life, and performance in elite athletes with allergic rhinoconjunctivitis. Clin J Sport Med 2002; 12:296-300.
31. Neffen H, Mello JF Jr, Sole D et al. Nasal allergies in the Latin American population: results from the Allergies in Latin America survey. Allergy Asthma Proc 2010; 31(Suppl 1):S9-27.
32. Nascimento Silva M, Naspitz C, Solé D. Evaluation of quality of life in children and teenagers with allergic rhinitis: adaptation and validation of the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ). Allergol Immunopathol (Madr) 2001; 29:111-8.
33. Ferrer M, Morais-Almeida M, Guizova M, Khanferyan R. Evaluation of treatment satisfaction in children with allergic disease treated with an antihistamine: an international, non interventional, retrospective study. Clin Drug Investig 2010; 30:15-34.
34. Leong KP, Yeak SC, Saurajen AS et al. Why generic and disease-specific quality-of-life instruments should be used together for the evaluation of patients with persistent allergic rhinitis. Clin Exp Allergy 2005; 35:288-98.
35. Leong KP, Chan SP, Tang CY et al. Quality of life of patients with perennial allergic rhinitis: preliminary validation of the Rhinoconjunctivitis Quality of Life Questionnaire in Singapore. Asian Pac J Allergy Immunol 1999; 17:163-7.
36. Zar HJ, Ehrlich RI, Workman L, Weinberg EG. The changing prevalence of asthma, allergic rhinitis and atopic eczema in African adolescents from 1995 to 2002. Pediatr Allergy Immunol 2007; 18:560-5.
37. Green RJ, Davis G, Price D. Concerns of patients with allergic rhinitis: the Allergic Rhinitis Care Programme in South Africa. Prim Care Respir J 2007; 16:299-303.
38. Potter PC; Paediatric Levocetirizine Study Group. Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial. Ann Allergy Asthma Immunol 2005; 95:175-80.
39. Potter PC, Van Niekerk CH, Schoeman HS. Effects of triamcinolone on quality of life in patients with persistent allergic rhinitis. Ann Allergy Asthma Immunol 2003; 91:368-74.
40. Gunhan K, Unlu H, Yuceturk AV, Songu M. Intranasal steroids or radiofrequency turbinoplasty in persistent allergic rhinitis: effects on quality of life and objective parameters. Eur Arch Otorhinolaryngol 2011; 268:845-50.
41. Kalpaklioglu AF, Kavut AB. Comparison of azelastine versus triamcinolone nasal spray in allergic and nonallergic rhinitis. Am J Rhinol Allergy 2010; 24:29-33.
42. Cingi C, Ozlugedik S. Effects of montelukast on quality of life in patients with persistent allergic rhinitis. Otolaryngol Head Neck Surg 2010; 142:654-8.
43. Cingi C, Yaz A, Cakli H, Ozudogru E, Kecik C, Bal C. The effects of phototherapy on quality of life in allergic rhinitis cases. Eur Arch Otorhinolaryngol 2009; 266:1903-8.
44. Yuksel H, Yilmaz O, Alkan S, Bayrak Deǧirmenci P, Kirmaz C. Validity and reliability of Turkish version of rhinitis and mini-rhinitis quality of life questionnaires. Allergol Immunopathol (Madr) 2009; 37:293-7.
45. Yüksel H, Yilmaz O, Söǧüt A, Eser E. Validation and reliability study of the Turkish version of the Pediatric Rhinitis Quality of Life Questionnaire. Turk J Pediatr 2009a; 51:361-6.
46. Yuksel H, Yilmaz O, Sogut A, Ertan P, Onur E. Correlation of quality of life with clinical parameters and eosinophilic cation protein levels in children with allergic rhinoconjunctivitis. Int Arch Allergy Immunol 2009; 148:18-22.
47. Kalpaklioǧlu AF, Kavut AB, Ekici M. Allergic and nonallergic rhinitis: the threat for obstructive sleep apnea. Ann Allergy Asthma Immunol 2009; 103:20-5.
48. Kalpaklioǧlu AF, Kavut AB. Allergic and nonallergic rhinitis: can we find the differences/similarities between the two pictures? Asthma 2009a; 46:481-5.
49. Kalpaklioǧlu AF, Baççioǧlu A. Evaluation of quality of life: impact of allergic rhinitis on asthma. J Investig Allergol Clin Immunol 2008; 18:168-73.
50. Pinar E, Eryigit O, Oncel S, Calli C, Yilmaz O, Yuksel H. Efficacy of nasal corticosteroids alone or combined with antihistamines or montelukast in treatment of allergic rhinitis. Auris Nasus Larynx 2008; 35:61-6.
51. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14:540-5.
52. Izci B, Ardic S, Firat H, Sahin A, Altinors M, Karacan I. Reliability and validity studies of the Turkish version of the Epworth Sleepiness Scale. Sleep Breath 2008; 12:161-8.
53. Colás C, Galera H, Añibarro B et al. Disease severity impairs sleep quality in allergic rhinitis (The SOMNIAAR study). Clin Exp Allergy 2012; 42:1080-7.
54. Katelaris C, Dhong H-J, Yip LAK, Vicente GM, Narayanan P. Patterns of allergic rhinitis and asthma in adults and children in Asia Pacific: Findings from the Allergies in Asia Pacific Survey. http://allergiesinasiapacific.com (accessed on 11th October 2011).
55. Lai C, Sacks R, Rhee C-S, Lee SH, Katelaris C. Impact on quality of life and performance in adults and children with allergic rhinitis in Asia Pacific: Findings from the Allergies in Asia Pacific Survey. http://allergiesinasiapacific.com (accessed on 11th October 2011).
56. Wallace DV, Dykewicz MS, Bernstein DI et al. The Diagnosis and Management of Rhinitis: an Updated Practice Parameter. Joint Task Force on Practice Parameters. J Allergy Clin Immunol 2008; 122:S1-84.
57. Maspero JF, Walters RD, Wu WW, Philpot EE, Naclerio RM, Fokkens WJ. An integrated analysis of the efficacy of fluticasone furoate nasal spray on individual nasal and ocular symptoms of seasonal allergic rhinitis. Allergy Asthma Proc 2010; 31:483-92.
58. National Heart, Lung, and Blood Institute. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma -Full Report 2007; http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf (accessed on 5th October 2010).
59. Marple BF, Fornadley JA, Patel AA et al. Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction. Otolaryngol Head Neck Surg 2007; 136(6 Suppl):S107-24.
60. Solari JE, Loo J, Felices A, Casas J. Immunotherapy for patients with persistent allergic rhinitis unsatisfied with free chronic pharmacotherapy. Allergol Immunopathol (Madr) 2006; 34:102-6.
61. Schatz M, Meltzer EO, Nathan R et al. Psychometric validation of the rhinitis control assessment test: a brief patient-completed instrument for evaluating rhinitis symptom control. Ann Allergy Asthma Immunol 2010; 104:118-24.
62. Fonseca JA, Nogueira-Silva L, Morais-Almeida M et al. Validation of a questionnaire (CARAT10) to assess rhinitis and asthma in patients with asthma. Allergy 2010; 65:1042-8.
63. Bousquet PJ, Combescure C, Neukirch F et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy 2007; 62:367-72.
64. Bousquet PJ, Combescure C, Klossek JM, Daure's JP, Bousquet J. Change in visual analogue scale in a pragmatic randomized cluster trial of allergic rhinitis. J Allergy Clin Immunol 2009; 123:149-54.
65. Demoly P, Jankowski R, Chassany O, Bessah Y, Allaert F-A. Validation of a self-questionnaire for assessing the control of allergic rhinitis. Clin Exp Allergy 2011; 41:860-8.
66. Miri S, Farid R, Akbari H, Amin R. Prevalence of allergic rhinitis and nasal smear eosinophilia in 11- to 15 yr-old children in Shiraz. Pediatr Allergy Immunol 2006; 17:519-23.
67. Keskin O, Tuncer A, Adalioglu G, Sekerel BE, Saçkesen C, Kalayci O. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis. Pediatr Allergy Immunol 2006; 17:396-407.
68. O'Meara TJ, Sercombe JK, Morgan G, Reddel HK, Xuan W, Tovey ER. The reduction of rhinitis symptoms by nasal filters during natural exposure to ragweed and grass pollen. Allergy 2005; 60:529-32.
69. Ng ML, Warlow RS, Chrishanthan N, Ellis C, Walls R. Preliminary criteria for the definition of allergic rhinitis: a systematic evaluation of clinical parameters in a disease cohort (I). Clin Exp Allergy 2000; 30:1314-31.
70. Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994; 94:182-8.
71. Revicki DA, Leidy NK, Brennan-Diemer F, Thompson C, Togias A. Development and preliminary validation of the multiattribute Rhinitis Symptom Utility Index. Qual Life Res 1998; 7:693-702.
72. Lo PS, Tong MC, Revicki DA et al. Rhinitis Symptom Utility Index (RSUI) in Chinese subjects: a multiattribute patient-preference approach. Qual Life Res 2006; 15:877-87.
73. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardised version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol 1999; 104:364-9.
74. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Development and validation of the Mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 2000; 30:132-40.
75. Juniper EF, Howland WC, Roberts NB, Thompson AK, King DR. Measuring quality of life in children with rhinoconjunctivitis. J Allergy Clin Immunol 1998; 101:163-70.
76. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991; 21:77-83.
77. Thomas M, Kay S, Pike J et al. The Asthma Control Test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey. Prim Care Respir J 2009; 18:41-9.
78. Meltzer EO, Busse WW, Wenzel SE et al. Use of the Asthma Control Questionnaire to predict future risk of asthma exacerbation. J Allergy Clin Immunol 2011; 127:167-72.
79. Schultz AB, Edington DW. Employee health and presenteeism: a systematic review. J Occup Rehabil 2007; 17:547-79.
80. Lamb CE, Ratner PH, Johnson CE et al. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective. Curr Med Res Opin 2006; 22:1203-10.